Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences

SAN DIEGO, Nov. 3, 2021 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that the Company will participate in the following upcoming virtual investor conferences:

Stifel 2021 Virtual Healthcare Conference
Date: Tuesday, November 16, 2021
Time: 2:40pm ET

Piper Sandler 33rd Annual Virtual Healthcare Conference
Date: Monday, November 22, 2021
Time: Pre-record available at 10:00am ET

Webcasts will be available on the Investors & Media Section of the Poseida website,  An archived replay of each webcast will be available for approximately 30 days following each presentation.